Web Desk -Pharmaceutical company Astra Zeneca says that according to research conducted in the United States, the use of its vaccine against coronavirus has established a strong defense system against the disease in adults.
Associated Press (AP) Research
According to the Associated Press (AP), the research study will restore public confidence in the company's vaccine and the findings are an important step toward approving the vaccine's use in the United States.
The vaccine given to 3,000 people during the study was 79% effective.Older people were also included in the study.None of the people who volunteered in the research experiments had a serious illness or hospitalization, compared to five when they received a dummy vaccine.
Safety Concerns: Many European Countries Stop Using AstraZeneca Vaccine.
Research in the United States and the United Kingdom and other countries have similar results.
The Astra Zeneca company has said that its independent testing of the vaccine's safety did not reveal any side effects.The study found that there were no reports of blood clots from the vaccine in Europe.
It should be noted that the use of this vaccine was stopped in many countries in Europe after reports of blood clots.
Mini Pangalos, the company's top researcher, told the Associated Press that it was hoped that research in the United States would clear up any doubts about the vaccine's effectiveness.Now the vaccine will be used in other parts of the world.
0 Comments